Examkin

Question

Difficulty: Very hardPediatric Infectious Diseases

A male neonate, aged 16 days, is evaluated in the emergency department in mid-winter due to a 24-hour history of poor feeding, rhinorrhea, and a documented axillary temperature of 38.4°C (101.1°F). He was born at 39 weeks gestation via uncomplicated vaginal delivery and discharged on day 2 of life. On physical examination, the patient appears well-perfused but exhibits mild tachypnea with a respiratory rate of 64/min. Auscultation of the chest reveals diffuse high-pitched expiratory wheezing and mild intercostal retractions. Dermatologic examination shows a splotchy, erythematous macular rash with central tiny yellow papules scattered across the chest and abdomen. A rapid antigen detection test for respiratory syncytial virus (RSV) returns positive. What is the most appropriate single best action in the management of this patient?

  1. Admit to the hospital, perform a full sepsis evaluation including cerebrospinal fluid culture, and initiate intravenous ampicillin and gentamicin.Answer
  2. B
    Administer a trial of nebulized albuterol, reassure the parents regarding the benign nature of the illness, and discharge home.
  3. C
    Admit the patient for supportive hydration and oxygenation; withhold empiric antibacterial therapy due to the confirmed viral etiology.
  4. D
    Obtain surface viral swabs of the cutaneous lesions and initiate intravenous acyclovir for suspected disseminated infection.
  5. E
    Discharge home with supportive care instructions and administer the live-attenuated intranasal influenza vaccine to prevent viral co-infection.

Answer

The most appropriate action is to admit the patient for a complete sepsis evaluation (including blood, urine, and cerebrospinal fluid cultures) and immediately initiate empiric intravenous antibiotics, such as ampicillin and gentamicin.
Any neonate aged 21 days or younger presenting with a fever (temperature ≥ 38.0°C or 100.4°F) is at exceptionally high risk for a serious bacterial infection (SBI), including bacteremia, urinary tract infection, or meningitis. The immature neonatal immune system fails to localize infections efficiently. Even in the presence of a confirmed viral infection (such as the RSV bronchiolitis seen in this patient) and a benign rash (erythema toxicum neonatorum), the risk of a concurrent, life-threatening bacterial sepsis remains unacceptably high. Therefore, standard protocol mandates an immediate, complete sepsis workup—consisting of blood, urine, and cerebrospinal fluid (CSF) cultures—followed promptly by empiric intravenous antibiotics. The standard regimen includes ampicillin (to cover *Listeria monocytogenes* and *Streptococcus agalactiae*) combined with gentamicin or cefotaxime (to cover gram-negative enteric organisms like *Escherichia coli*).

Step-by-Step Solution

1
Identify the patient's exact age and primary vital sign abnormality.
The patient is a 16-day-old neonate with a documented fever of 38.4°C (101.1°F).
Age and fever status dictate the algorithm for pediatric infectious disease management; infants ≤ 21 days are in the highest risk category.
2
Analyze concurrent clinical findings (respiratory distress, rash, positive RSV).
The patient has confirmed RSV bronchiolitis and a classic presentation of erythema toxicum neonatorum (benign splotchy erythema with yellow papules).
It is critical to recognize these findings to avoid being distracted from the overarching danger of the fever.
3
Apply the clinical rule for management of the febrile neonate.
Determine that despite the positive viral swab and benign dermatologic findings, the high risk of concurrent serious bacterial infection (SBI) remains.
The neonatal immune system is immature. Viral infections do not preclude concurrent dangerous bacterial infections like meningitis or bacteremia in the first 3 weeks of life.
4
Select the correct intervention suite.
Choose full pan-culturing (blood, urine, CSF) and empiric administration of ampicillin (for Listeria/Group B Strep) and gentamicin (for Gram-negatives).
This is the universal standard of care to prevent mortality from neonatal sepsis.

Key Concept

Management protocols for the febrile neonate (≤ 21 days old)
Rate this question

Topics

Pediatric Infectious Diseases

More questions from this topic